These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


440 related items for PubMed ID: 23604229

  • 1. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, Ketterling RP, Maxson JE, Tyner JW, Tefferi A.
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y, Qiao C, Chen Y, Zhang SJ.
    Oncotarget; 2017 Mar 28; 8(13):20834-20841. PubMed ID: 28209919
    [Abstract] [Full Text] [Related]

  • 3. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y, Chen Y, Li X.
    Ann Hematol; 2021 Jun 28; 100(6):1459-1461. PubMed ID: 33822276
    [Abstract] [Full Text] [Related]

  • 4. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A, Gao J, Chen YH, Abaza Y, Altman J, Jennings L, Vormittag-Nocito E, Sukhanova M, Lu X, Chen Q.
    Hum Pathol; 2024 Jul 28; 149():66-74. PubMed ID: 38879086
    [Abstract] [Full Text] [Related]

  • 5. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
    Kim SY, Song IC, Kim J, Kwon GC.
    Ann Diagn Pathol; 2024 Aug 28; 71():152317. PubMed ID: 38642470
    [Abstract] [Full Text] [Related]

  • 6. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A, Elliott M, Pardanani A.
    Curr Opin Hematol; 2015 Mar 28; 22(2):171-6. PubMed ID: 25575036
    [Abstract] [Full Text] [Related]

  • 7. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N, Orazi A, Tefferi A.
    Am J Hematol; 2024 Jul 28; 99(7):1360-1387. PubMed ID: 38644693
    [Abstract] [Full Text] [Related]

  • 8. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia.
    Cui Y, Li B, Gale RP, Jiang Q, Xu Z, Qin T, Zhang P, Zhang Y, Xiao Z.
    J Hematol Oncol; 2014 Oct 15; 7():77. PubMed ID: 25316523
    [Abstract] [Full Text] [Related]

  • 9. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
    Maxson JE, Luty SB, MacManiman JD, Paik JC, Gotlib J, Greenberg P, Bahamadi S, Savage SL, Abel ML, Eide CA, Loriaux MM, Stevens EA, Tyner JW.
    Clin Cancer Res; 2016 Feb 01; 22(3):757-64. PubMed ID: 26475333
    [Abstract] [Full Text] [Related]

  • 10. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A, Arenillas L, Martínez-Avilés L, Fernández-Rodríguez C, Bellosillo B, Florensa L, Besses C, Álvarez-Larrán A.
    Med Clin (Barc); 2015 Jun 08; 144(11):487-90. PubMed ID: 24854193
    [Abstract] [Full Text] [Related]

  • 11. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB, Wu WW, Zhou Y, Wang X, Li J, Yu Y.
    BMC Cancer; 2018 Mar 27; 18(1):343. PubMed ID: 29587671
    [Abstract] [Full Text] [Related]

  • 12. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT, Tyner JW, Gotlib J.
    Curr Hematol Malig Rep; 2017 Oct 27; 12(5):432-441. PubMed ID: 28983816
    [Abstract] [Full Text] [Related]

  • 13. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B, Chen X, Gao F, Li J, Wang HW.
    Hematology; 2019 Dec 27; 24(1):538-543. PubMed ID: 31315541
    [Abstract] [Full Text] [Related]

  • 14. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
    Elliott MA, Pardanani A, Hanson CA, Lasho TL, Finke CM, Belachew AA, Tefferi A.
    Am J Hematol; 2015 Jul 27; 90(7):653-6. PubMed ID: 25850813
    [Abstract] [Full Text] [Related]

  • 15. What's different about atypical CML and chronic neutrophilic leukemia?
    Dao KH, Tyner JW.
    Hematology Am Soc Hematol Educ Program; 2015 Jul 27; 2015():264-71. PubMed ID: 26637732
    [Abstract] [Full Text] [Related]

  • 16. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC, Szybinski J, Halter JP, Cantoni N, Wenzel F, Leonards K, Brkic S, Passweg JR, Touw I, Maxson JE, Meyer SC.
    Curr Oncol; 2022 Feb 01; 29(2):805-815. PubMed ID: 35200567
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT, Gotlib J, Deininger MMN, Oh ST, Cortes JE, Collins RH, Winton EF, Parker DR, Lee H, Reister A, Schultz, Savage S, Stevens, Brockett C, Subbiah N, Press RD, Raess PW, Cascio M, Dunlap J, Chen Y, Degnin C, Maxson JE, Tognon CE, Macey T, Druker BJ, Tyner JW.
    J Clin Oncol; 2020 Apr 01; 38(10):1006-1018. PubMed ID: 31880950
    [Abstract] [Full Text] [Related]

  • 18. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
    Elliott MA, Tefferi A.
    Curr Opin Hematol; 2014 Mar 01; 21(2):148-54. PubMed ID: 24335708
    [Abstract] [Full Text] [Related]

  • 19. [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].
    Cui Y, Li B, Jiang Q, Xu Z, Qin T, Zhang P, Zhang Y, Xiao Z.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec 01; 35(12):1069-73. PubMed ID: 25543699
    [Abstract] [Full Text] [Related]

  • 20. Genomics of chronic neutrophilic leukemia.
    Maxson JE, Tyner JW.
    Blood; 2017 Feb 09; 129(6):715-722. PubMed ID: 28028025
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.